NECTAR LIFESCIENCES
Back to Income Statement
|
NECTAR LIFESCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-114 Cr | ₹5.00 Cr | ₹-24 Cr | ₹25 Cr | ₹-73 Cr |
What is the latest Consolidated Net Profit of NECTAR LIFESCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-114 Cr |
| Mar2024 | ₹5.00 Cr |
| Mar2023 | ₹-24 Cr |
| Mar2022 | ₹25 Cr |
| Mar2021 | ₹-73 Cr |
How is Consolidated Net Profit of NECTAR LIFESCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-114 Cr | Negative | |
| Mar2024 | ₹5.00 Cr | Positive | |
| Mar2023 | ₹-24 Cr | Negative | |
| Mar2022 | ₹25 Cr | Positive | |
| Mar2021 | ₹-73 Cr | - | |
Compare Consolidated Net Profit of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹226.4 Cr | 1.1% | -6.3% | -43.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,924.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹118,361.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | 1.1% |
-6.3% |
-43.3% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses